Unclaimed Scholar Profile
Are you Ahmed Aziz Bousfiha? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at Centre Hospitalier Universitaire Ibn RochdASIDASID-3959-6416-0384 orcid.org/0000-0002-5011-9873
Ahmed Aziz Bousfiha
Centre Hospitalier Universitaire Ibn Rochd
Faculty researcher at Centre Hospitalier Universitaire Ibn Rochd (MA), specializing in Physical Sciences & Engineering. [Discipline: Physical Sciences & Engineering] [Scholar Type: Journal Research Scientist] [Career Tier: Distinguished Scholar] [Region: North Africa]
#Immunodeficiency and Autoimmune Disorders#Blood disorders and treatments#T-cell and B-cell Immunology#Autoimmune and Inflammatory Disorders Research
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 10,224 | 4,908 |
| h-index | 32 | 24 |
| i10-index | 53 | 37 |
Annual Citation Growth
Verified Citations / Year0
2020491
2021+40%687
2022+29%883
2023+33%1.2k
2024-8%1.1k
2025-45%589
2026Scholarship Distribution & Proportions213 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:25% African Regional Citations (2,556) • 75% Global Research Impact (7,668)
213 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (213)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Published in Science•2020
DOI: 10.1126/science.abd4585 Verified Peer-Reviewed
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
Published in Science Immunology•2021
DOI: 10.1126/sciimmunol.abl4340 Verified Peer-Reviewed
Revisiting Human IL-12Rβ1 Deficiency
Published in Medicine•2010
DOI: 10.1097/md.0b013e3181fdd832 Verified Peer-Reviewed
Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee
Published in Journal of Human Immunity•2025
DOI: 10.70962/jhi.20250003 Verified Peer-Reviewed
Primary Immunodeficiency Diseases Worldwide: More Common than Generally Thought
Published in Journal of Clinical Immunology•2012
DOI: 10.1007/s10875-012-9751-7 Verified Peer-Reviewed
Showing 1 – 5 of 213 publications
1 / 43
